Skip to main content
Top

International Journal of Hematology

Issue 6/2019

Content (17 Articles)

Anaphylaxis Images in Hematology

Idiopathic anaphylaxis and systemic mastocytosis

Ivo M. B. Francischetti, Irina Maric

Leukocytosis Images in Hematology

A megakaryocyte in a peripheral blood smear

Tokiko Nakai, Yasuyuki Okamoto

Filgrastim Original Article

Evaluation of a biosimilar granulocyte colony-stimulating factor for peripheral blood stem cell mobilization in Japanese healthy donors: a prospective study

Keijiro Sato, Ken Ishiyama, Go Aoki, Hiroyuki Maruyama, Noriaki Tsuji, Mikoto Tanabe, Yoshitaka Zaimoku, Hidehiro Sato, Hirohito Yamazaki, Masaki Yamaguchi, Akiyoshi Takami, Shinji Nakao

Acute Myeloid Leukemia Original Article

Safety and pharmacokinetics of quizartinib in Japanese patients with relapsed or refractory acute myeloid leukemia in a phase 1 study

Kensuke Usuki, Hiroshi Handa, Ilseung Choi, Takahiro Yamauchi, Hiroatsu Iida, Tomoko Hata, Shoichi Ohwada, Noriko Okudaira, Kota Nakamura, Sakura Sakajiri

Acute Myeloid Leukemia Original Article

Efficacy and safety of quizartinib in Japanese patients with FLT3-ITD positive relapsed or refractory acute myeloid leukemia in an open-label, phase 2 study

Takeshi Takahashi, Kensuke Usuki, Kosei Matsue, Hitoshi Ohno, Toru Sakura, Ryota Imanaka, Masato Murakami, Shoichi Ohwada, Taiga Takagi, Sakura Sakajiri

Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt)

Koji Nagafuji, Itaru Matsumura, Takayuki Shimose, Tatsuya Kawaguchi, Junya Kuroda, Hirohisa Nakamae, Toshihiro Miyamoto, Norimitsu Kadowaki, Jun Ishikawa, Yutaka Imamura, Hirohito Yamazaki, Koichi Akashi, Yuzuru Kanakura

Primary Myelofibrosis Original Article

TERT and JAK2 polymorphisms define genetic predisposition to myeloproliferative neoplasms in Japanese patients

Masafumi Matsuguma, Toshiaki Yujiri, Kaoru Yamamoto, Yasuko Kajimura, Yoshihiro Tokunaga, Mayumi Tanaka, Yoshinori Tanaka, Yukinori Nakamura, Yukio Tanizawa

Primary Myelofibrosis Original Article

Novel lysyl oxidase inhibitors attenuate hallmarks of primary myelofibrosis in mice

Orly Leiva, Seng Kah Ng, Shinobu Matsuura, Vipul Chitalia, Hector Lucero, Alison Findlay, Craig Turner, Wolfgang Jarolimek, Katya Ravid

Inotuzumab ozogamicin versus standard of care in Asian patients with relapsed/refractory acute lymphoblastic leukemia

Naohito Fujishima, Toshiki Uchida, Yasushi Onishi, Chul Won Jung, Yeow Tee Goh, Kiyoshi Ando, Ming Chung Wang, Chiho Ono, Miyako Matsumizu, M. Luisa Paccagnella, Barbara Sleight, Erik Vandendries, Yosuke Fujii, Masayuki Hino

Lymphoma Original Article

Successful outcome with reduced-intensity condition regimen followed by allogeneic hematopoietic stem cell transplantation for relapsed or refractory anaplastic large-cell lymphoma

Reiji Fukano, Tetsuya Mori, Naoto Fujita, Ryoji Kobayashi, Tetsuo Mitsui, Koji Kato, Ritsuro Suzuki, Junji Suzumiya, Takahiro Fukuda, Motohiro Shindo, Nobuo Maseki, Tatsu Shimoyama, Keiko Okada, Masami Inoue, Jiro Inagaki, Yoshiko Hashii, Atsushi Sato, Ken Tabuchi

Granulocyte Transfusion Original Article

Successful granulocyte apheresis using medium molecular weight hydroxyethyl starch

Mai Nanya, Kimiko Yurugi, Itaru Kato, Hidefumi Hiramatsu, Hiroshi Kawabata, Tadakazu Kondo, Tomoki Iemura, Rie Hishida, Erika Shibutani, Keiko Matsui, Yoko Nakagawa, Norimi Niwa, Yasunari Kasai, Joseph M. Roig, Yasuyuki Arai, Yasuo Miura, Akifumi Takaori-Kondo, Taira Maekawa, Hideyo Hirai

Phase I study of graft-versus-host disease prophylaxis including bortezomib for allogeneic hematopoietic cell transplantation from unrelated donors with one or two HLA loci mismatches in Japanese patients

Takahiko Nakane, Hiroshi Okamura, Yumi Tagaito, Shiro Koh, Takuro Yoshimura, Yosuke Makuuchi, Satoru Nanno, Mika Nakamae, Asao Hirose, Yasuhiro Nakashima, Hideo Koh, Masayuki Hino, Hirohisa Nakamae

Supportive care for hemostatic complications associated with pediatric leukemia: a national survey in Japan

Shinya Osone, Keitaro Fukushima, Michihiro Yano, Mariko Kakazu, Hirozumi Sano, Yoko Kato, Yuichi Shinkoda, Kunihiro Shinoda, Naoko Mori, Souichi Adachi

Vasculitis Case Report

Cryoglobulinemic vasculitis with interruption of ibrutinib therapy for chronic lymphocytic leukemia (CLL)

Nicholas Wright, Ensi Voshtina, Gemlyn George, Arun Singavi, Joshua Field

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine